Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Jul 15;200(2):121-123.
doi: 10.1164/rccm.201901-0180ED.

Subclinical Interstitial Lung Abnormalities: Lumping and Splitting Revisited

Simon L F Walsh  1 , Luca Richeldi  2
Affiliations
Comment

Subclinical Interstitial Lung Abnormalities: Lumping and Splitting Revisited

Simon L F Walsh et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Progressive fibrotic interstitial lung abnormalities (ILAs) represent a subtype of ILAs that progress to symptomatic progressive fibrotic interstitial lung disease (PF-ILD), of which idiopathic pulmonary fibrosis (IPF) is one form. The challenge is to determine with accuracy which forms of ILA belong to the progressive fibrotic ILA subtype.
See this image and copyright information in PMC

Comment on

  • Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality.
    Putman RK, Gudmundsson G, Axelsson GT, Hida T, Honda O, Araki T, Yanagawa M, Nishino M, Miller ER, Eiriksdottir G, Gudmundsson EF, Tomiyama N, Honda H, Rosas IO, Washko GR, Cho MH, Schwartz DA, Gudnason V, Hatabu H, Hunninghake GM. Putman RK, et al. Am J Respir Crit Care Med. 2019 Jul 15;200(2):175-183. doi: 10.1164/rccm.201809-1652OC. Am J Respir Crit Care Med. 2019. PMID: 30673508 Free PMC article.

References

    1. Putman RK, Hatabu H, Araki T, Gudmundsson G, Gao W, Nishino M, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators; COPDGene Investigators. Association between interstitial lung abnormalities and all-cause mortality. JAMA. 2016;315:672–681. - PMC - PubMed
    1. Washko GR, Hunninghake GM, Fernandez IE, Nishino M, Okajima Y, Yamashiro T, et al. COPDGene Investigators. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med. 2011;364:897–906. - PMC - PubMed
    1. Sverzellati N, Guerci L, Randi G, Calabrò E, La Vecchia C, Marchianò A, et al. Interstitial lung diseases in a lung cancer screening trial. Eur Respir J. 2011;38:392–400. - PubMed
    1. Hunninghake GM, Hatabu H, Okajima Y, Gao W, Dupuis J, Latourelle JC, et al. MUC5B promoter polymorphism and interstitial lung abnormalities. N Engl J Med. 2013;368:2192–2200. - PMC - PubMed
    1. Lederer DJ, Enright PL, Kawut SM, Hoffman EA, Hunninghake G, van Beek EJ, et al. Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study. Am J Respir Crit Care Med. 2009;180:407–414. - PMC - PubMed